Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shengjin Runkou Yin is a Traditional Chinese Medicine (TCM) hospital-made preparation (院内制剂) developed by the Guangdong Provincial Hospital of Traditional Chinese Medicine. It is primarily indicated for the treatment of Sjögren's syndrome and other conditions characterized by xerostomia (dry mouth) and dry throat. The formula is designed to nourish Yin and promote the production of body fluids (Shengjin). It typically contains herbal ingredients such as *Ophiopogon japonicus*, *Scrophularia ningpoensis*, and *Rehmannia glutinosa*. Clinical use focuses on relieving symptoms of dryness by improving salivary gland function and oral mucosal moisture. Research suggests that the formula may exert its therapeutic effects by upregulating the expression of water channel proteins, specifically Aquaporin-5 (AQP5), in the salivary glands.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shengjin runkou yin.